Pharmacokinetics of systemic versus focal carboplatin chemotherapy in the rabbit eye: Possible implication in the treatment of retinoblastoma

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 10, 2004, Pages 3644-3649

  Hayden, Brandy C ^a   Jockovich, Maria Elena ^a   Murray, Timothy G ^a   Voigt, Monika ^a,c   Milne, Peter ^a,b   Kralinger, Martina ^a,d   Feuer, William J ^a   Hernandez, Eleut ^a   Parel, Jean Marie ^a,e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHOROID; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; DRUG TISSUE LEVEL; EYE TOXICITY; INFUSION; IONTOPHORESIS; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RABBIT; RETINA; RETINOBLASTOMA; VITREOUS BODY;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHOROID; EYE; INFUSIONS, INTRAVENOUS; INJECTIONS; IONTOPHORESIS; OPTIC NERVE; RABBITS; RETINA; RETINAL NEOPLASMS; RETINOBLASTOMA; SPECTROPHOTOMETRY, ATOMIC; TISSUE DISTRIBUTION; VITREOUS BODY;

EID: 4644256574     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0228     Document Type: Article

References (52)

1. Murphree AL, Villablanca JG, Deegan WF III, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1348-1356.
2. Kingston JE, Plowman PN, Hungerford JL. Ectopic intracranial retinoblastoma in childhood. Br J of Ophthalmol. 1985;69:742-748.
3. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy (published correction appears in Arch Ophthalmol. 1997;115:525). Arch Ophthalmol. 1996;114:1321-1328.
4. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy (published correction appears in Arch Ophthalmol. 1997;115:525). Arch Ophthalmol. 1996;114:1321-1328.
5. Shields CL, Shields JA, Needle M, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1997;104:2101-2111.
6. Advani SH, Rao SR, Iyer RS, Pai SK, Kurkure PA, Nair CN. Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma (see comments). Med Pedriatr Oncol. 1994;22:125-128.
7. Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma: the experience of a single institution with 33 patients. Cancer. 1994;74:722-732.
8. Goble RR, McKenzie J, Kingston JE, Plowman PN, Hungerford JL. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br J Ophthalmol. 1990;74:97-98.
9. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18:12-17.
10. Shields JA, Augsburger JJ. Current approaches to the diagnosis and management of retinoblastoma. Surv Ophthalmol. 1981;25:347-372.
11. White L. Chemotherapy for retinoblastoma: where do we go from here? - a review of published literature and meeting abstracts, including discussions during the Vth International Symposium on Retinoblastoma, October 1990 (review). Ophthalmic Pediatr Genet. 1991;12:115-130.
12. White L. The role of chemotherapy in the treatment of retinoblastoma (review). Retina. 1983;3:194-199.
13. Bhisitkul RB, Mukai S. Emerging chemotherapeutic strategies in the management of intraocular retinoblastoma. Int Ophthalmol Clin. 1997;37:201-214.
14. White L. The role of chemotherapy in the treatment of retinoblastoma. Retina. 1983;1983;3:194-199.
15. White L. Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol. 1991;13:189-201.
16. Ettinger LJ, Gaynon PS, Krailo MD. A phase II study of carboplatin in children with recurrence of progressive solid tumors. Cancer. 1994;73:1297-1301.
17. Doz F, Pinkerton R. What is the place of carboplatin in paediatric oncology? Eur J Cancer. 1994;30:194-201.
18. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317:588-593.
19. Benz MS, Scott IU, Murray TG, Kramer D, Toledano S. Complications of systemic chemotherapy as treatment of retinoblastoma. Arch of Ophthalmol. 2000;118:577-578.
20. Scott IU, Murray TG, Toledano S, O'Brien JM. New retinoblastoma tumors in children undergoing systemic chemotherapy (letter). Arch Ophthalmol. 1998;116:1685-1686.
21. Lee TC, Hayashi NI, Dunkel IJ, Beaverson K, Novetsky D, Abramson DH. New retinoblastoma tumor formation in children initially treated with systemic carboplatin. Ophthalmology. 2003;110:1989-9194.
22. Murray TG, Roth DB, O'Brien JM, et al. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma. Arch Ophthalmol. 1996;114:1385-1389.
23. Murray TG, Cicciarelli N, McCabe CM, et al. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line. Invest Ophthalmol Vis Sci. 1997;38:2516-2522.
24. Harbour JW, Murray TG, Hamasaki D, et al. Local carboplatin therapy in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci. 1996;37:1892-1898.
25. Hayden BC, Murray TG, Scott IU, et al. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule. Arch Ophthalmol. 2000;118:1549-1554.
26. Abramson DH, Frank CM, Chantada GL, et al. Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma. Ophthalmic Genet. 1999;20:31-36.
27. Abramson DH, Frank CM, Dunkel IJ. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology. 1999;106:1947-1950.
28. Mendelsohn ME, Abramson DH, Madden T, Tong W, Tran HT, Dunkel IJ. Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Arch Ophthalmol. 1998;116:1209-1212.
29. Behar-Cohen FF, Parel JM, Pouliquen Y, et al. Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Exp Eye Res. 1997;65:533-545.
30. Behar-Cohen FF, Savoldelli M, Parel JM, et al. Reduction of corneal edema in endotoxin-induced uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis. Invest Ophthalmol Vis Sci. 1998;39:897-904.
31. Behar-Cohen FF, El Aouni A, Gautier S, et al. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels. Exp Eye Res 2002;74:51-59.
32. Voigt M, Kralinger M, Kieselbach G, et al. Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration. Invest Ophthalmol Vis Sci. 2002;43:3299-3306.
33. Kralinger MT, Voigt M, Kieselbach GF, Hamasaki D, Hayden BC, Parel JM. Ocular delivery of acetylsalicylic acid by repetitive Coulomb-controlled iontophoresis Ophthalmic Res. 2003;35:102-110.
34. Drummer O, Proudfoot A, Howes L, Louis W. High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method. Clin Chim Acta. 1984;136:65-74.
35. van Warmerdam L, van Tellingen O, Maes R, Beijnen J. Validated method for the determination of carboplatin in biological fluids by Zeeman atomic absorption spectrometry. Fresenius J Anal Chem. 1995;351:777-781.
36. Graver R, George A, Deeb G. In vitro stability, plasma protein binding and blood cell partitioning of 14C-carboplatin. Cancer Chemother Pharmacol. 1987;20:271-276.
37. Bornfeld N, Schuler A, Bechrakis N, Henze G, Havers W. Preliminary results of primary chemotherapy in retinoblastoma. Klin Padiatr. 1997;209:216-221.
38. Finger PT, Czechonska G, Demirci H, Rausen A. Chemotherapy for retinoblastoma: a current topic (review). Drugs. 1999;58:983-996.
39. Levy C, Doz F, Quintana E, et al. Role of chemotherapy alone or in combination with hypothermia in the primary treatment of intraocular retinoblastoma: preliminary results. Br J Ophthalmol. 1998;82:1154-1158.
40. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1330-1338.
41. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1339-1343.
42. Murray TG, Cicciarelli N, O'Brien JM, et al. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma. Arch Ophthalmol. 1997;115:1286-1290.
43. Sarraf D, Lee DA. The role of iontophoresis in ocular drug delivery (review). J Ocul Pharmacol. 1994;10:69-81.
44. Ashburn MA, Gauthier M, Love G, Basta S, Gaylord B, Kessler K. Iontophoretic administration of 2% lidocaine HCl and 1:100,000 epinephrine in humans. Clin J Pain. 1997;13:22-26.
45. Yoshizumi MO, Dessouki A, Lee DA, Lee G. Determination of ocular toxicity in multiple applications of foscarnet iontophoresis. J Ocul Pharmacol Ther. 1997;13:529-536.
46. Zheng X, Marquart ME, Loustch JM, et al. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty. Invest Ophthalmol Vis Sci. 1999;40:2490-2497.
47. Parel J-M, Behar-Cohen F, Davis J, Murray T, Yoo S. Non-invasive Topical Drug Delivery to Retina-Choroid via Coulomb Controlled Iontophoresis. Presented at the 30th meeting meeting of the Club Jules Gonin, Montreux Switzerland, 8/31-9/4, 2002.
48. Halhal M, Renard G, Courtois Y, BenEzra D, Behar-Cohen F. Iontophoresis: from the lab to the bed side. Exp Eye Res. 2004;78:751-757.
49. Shields CL, Shields JA. Recent developments in the management of retinoblastoma (review). J Pedriatr Ophthalmol Strabismus. 1999;36:8-18.
50. White L, Ortega JA, Ying KL. Acute non-lymphocytic leukemia following multimodality therapy for retinoblastoma. Cancer. 1985;55:496-498.
51. Shields CL, Shields JA, DePotter P, Himelstein BP, Meadows AT. The effect of chemoreduction on retinoblastoma-induced retinal detachment. J Pediatr Ophthalmol Strabismus. 1997;34:165-169.
52. Chan HSL, DeBoer G, Thiessen JJ, et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res. 1996;2:1499-1508.